Instituto Ramón y Cajal de Investigación Sanitaria

Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients

Felix Busch, Lena Hoffmann, Lina Xu et al.

2025 · 31 Zit.

Assessing the Integrity of Clinical Trials Included in Evidence Syntheses

María Núñez‐Núñez, Naomi Cano‐Ibáñez, Javier Zamora et al.

2023 · 23 Zit.

Artificial intelligence in COVID-19 evidence syntheses was underutilized, but impactful: a methodological study

Juan R. Tercero-Hidalgo, Khalid S. Khan, Aurora Bueno‐Cavanillas et al.

2022 · 20 Zit.

Measuring the impact factor of individual researchers in biomedical disciplines.

J. Ramos-Brieva, Amelia Cordero-Villafáfila

2014 · 8 Zit.

International multistakeholder consensus statement on post‐publication integrity issues in randomized clinical trials by Cairo Consensus Group

Khalid S. Khan, Mohamed Fawzy, Patrick Chien et al.

2025 · 5 Zit.

Post‐publication research integrity concerns in randomized clinical trials: A scoping review of the literature

Patrick Chien, Mohamad AlaaEldein Elsuity, Mosab Rashwan et al.

2024 · 5 Zit.

Enhancing physicians’ radiology diagnostics of COVID-19’s effects on lung health by leveraging artificial intelligence

Óscar Gasulla, María J. Ledesma‐Carbayo, Luisa N. Borrell et al.

2023 · 2 Zit.

Del algoritmo al paciente: el impacto de la inteligencia artificial en la práctica médica

C. García-Montero, O. Fraile-Martínez, D.L. Boaru et al.

2025 · 0 Zit.

CARE-AI: Cancer assessment risk estimation using artificial intelligence.

María García-Fraile, Marta Fernández, Julia Simón et al.

2025 · 0 Zit.